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ABSTRACT
The RNA binding protein Larp1 was originally shown
to be involved in spermatogenesis, embryogenesis
and cell-cycle progression in Drosophila. Our data
show that mammalian Larp1 is found in a complex
with poly A binding protein and eukaryote initiation
factor 4E and is associated with 60S and 80S ribo-
somal subunits. A reduction in Larp1 expression by
siRNA inhibits global protein synthesis rates and
results in mitotic arrest and delayed cell migration.
Consistent with these data we show that Larp1
protein is present at the leading edge of migrating
cells and interacts directly with cytoskeletal compo-
nents. Taken together, these data suggest a role for
Larp1 in facilitating the synthesis of proteins
required for cellular remodelling and migration.
INTRODUCTION
Normal epithelial cells display a regular structure, are
joined to neighbouring cells, have a characteristic
apico-basal polarity and minimal ability to migrate (1).
In physiological states such as embryonic development,
wound healing and immunity, epithelial cells undergo
cytoskeletal and cell signalling changes to become motile
(2–4). This also occurs in pathological processes such as
cancer invasion and metastasis where cells acquire migra-
tory or mesenchymal characteristics. The complex alter-
ations in cell signalling required for this process [reviewed
in ref. (5)] result in a series of cellular changes including
detachment from neighbouring cells, loss of apico-basal
polarity, formation of a spindle-shaped morphology and
the ability to migrate through the extracellular matrix
(ECM) (6). Migration requires the activation of localized
actin polymerization at the ‘leading edge’ of the cell to
form protrusive structures beneath the plasma
membrane, such as ﬂat lamellipodia and ﬁnger-like
ﬁlopodia (7,8). In addition, actin-based stress ﬁbres and
focal adhesions are formed, providing attachment and
traction between the cell and the ECM. Forward gliding
in the direction of the leading edge is achieved through
interactions between these actin ﬁlaments and contractile
proteins such as myosin II (9). Disruption of intercellular
junctions allows detachment from neighbouring cells, and
digestion of the surrounding ECM by proteolytic enzymes
permits 2D (amoeboid) migration (10,11). Additionally,
dynamic protrusive structures called ‘invasive
pseudopodia’ form, which facilitate 3D (mesenchymal)
movement (12).
The acquisition of a migratory phenotype is triggered
by extracellular stimulants such as hepatocyte growth
factor and epithelial growth factor (13). The process
linking these signals to co-ordinated formation of
invasive components remains poorly understood. The
major downstream regulators of migration are the Rho
GTPases which primarily regulate lamellipodia and
ﬁlopodia formation via WAVE and formin (mDia/Drf)
pathways, respectively (14). Actin-binding and capping
proteins regulate actin ﬁlament assembly and disassembly
(15,16). Cell types vary in their proportions of
lamellipodia and ﬁlopodia, and some studies suggest
they are generated independently (17).
Many of these processes are controlled at the level of
messenger RNA (mRNA) translation. This occurs in three
steps. The ﬁrst or ‘initiation’ step is rate-limiting and
requires the binding of the eukaryotic initiation factor
(eIF)4F complex to the 50-end of the mRNA. The
complex contains the cap-binding protein eIF4E, a
scaﬀold protein, eIF4G and a helicase, eIF4A, which
unwinds the RNA (18). Assembly of the cap complex
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of the 40S ribosomal subunit and scanning to the ﬁrst
AUG or ‘start’ codon. Global regulation of mRNA trans-
lation is mainly achieved by directly altering the phos-
phorylation of eIFs or their binding partners. As well as
global regulation, transcript-speciﬁc regulation of transla-
tion occurs, mediated by interactions between trans-acting
factors and sequences within the 50 and/or 30 mRNA un-
translated regions (UTRs) (19). Inactive mRNA tran-
scripts can also be shuttled to speciﬁc cellular
destinations before protein synthesis is activated; this
spatio-temporal regulation of mRNA translation has
been demonstrated in embryogenesis and patterning in
Drosophila (20) and in meiotic spindle assembly and
chromosome condensation in Xenopus (21). In mamma-
lian axons, mRNAs encoding b-actin are stored in an
inactive state and transported to distal neuronal processes
following axonal injury to facilitate regeneration, achieved
through the binding of CPE-proteins to cis-acting se-
quences within their 30 or 50 UTR (22). In addition to a
role in development and axonal recovery, site-speciﬁc
protein synthesis is likely to be required for other asym-
metric cellular processes.
Larp1 was ﬁrst described in Drosophila and shown to be
required for spermatogenesis, embryogenesis and cell cycle
progression (23–25). Drosophila Larp1 interacts with poly
A binding protein (PABP) (25) suggesting the phenotype
observed in Larp1 mutants may be due to defective
mRNA translation or regulation, supported by the
ﬁnding in Caenorhabditis elegans that LARP-1 is an
RNA-binding protein (26). Although ﬁve Larp proteins
exist in the human genome, only two carry a combination
of a La domain, an RNA recognition motif and a DM15/
Larp1 region (Figure 1A); Larp1 and Larp1b (previously
named Larp2) (27). Larp 1 (positioned at 5q34) encodes a
1097 amino-acid protein with 50% identity to Drosophila
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Figure 1. (A) Larp proteins are conserved in metazoans and members of the Larp1 family contain an N-terminal La domain (similar to La proteins)
and a C-terminal conserved or Larp1 region containing DM15 tandem repeat regions (33). There is a single ‘Larp’ gene in D. melanogaster [now
termed DmLarp1 (27)] and two homologues in humans, Larp1 and Larp1b (previously termed Larp2) encoded by genes located at 5q33.2 and
4q28.2, respectively. Larp1 and Larp1b share 50 and 59% identity with Dm Larp1, respectively. There are two isoforms of Larp1 protein of 1019 and
1096 amino acids, respectively, and three isoforms of Larp1b protein of 914, 512 and 358 amino acids. (B) Of the two human Larp proteins, Larp1 is
more abundant than Larp1b as shown by qPCR in HeLa cells (after normalization to housekeeping genes). The relative expression level of Larp1b
(when standardized to 100% Larp1) was 2.5%, therefore Larp1 is 40-fold more abundant. (C) Immunoprecipitation, using antibodies to Larp1 and
PABP and protein G sepharose beads showed an interaction between Larp1 and PABP, as demonstrated using western blotting of the
immunoprecipitate. This interaction was not observed using beads alone (control) but was not disrupted following treatment with RNAse A. (D)
Western blot of protein pull-down using 7-Methyl-GTP cap-binding sepharose beads demonstrates that Larp1 exists in complex with eIF4E. As
expected, PABP and eIF4G were also ‘pulled down’ from the lysate using the cap beads in an association that was not disrupted after RNAse
treatment. Additionally, loss of Larp1 (by RNAi) did not remove the interaction between either PABP and eIF4E or eIF4G and eIF4E (data not
shown), suggesting these interactions are non-Larp1 dependent.
Nucleic Acids Research, 2010,Vol.38, No. 16 5543Larp1, and Larp1b (at 4q28) encodes a 915 amino acid
protein with 46% identity to Drosophila Larp1. Here we
demonstrate that Larp1 exists in complexes with both
PABP and eIF4E, and is required for ordered mitosis,
cell survival and migration.
MATERIALS AND METHODS
Cell culture
HeLa cells were maintained in DMEM supplemented with
L-glutamine (Gibco, 2mM), FCS (10%, First Link UK
Ltd.) and PenStrep (Gibco, 50U/ml). PE01 and PE04
cells were a kind gift from Dr Simon Langdon (CRUK,
Edinburgh) and maintained in RPMI supplemented as
earlier. The cell lines were kept at 37 Ca t5 %C O 2.
Qualitative real time PCR
RNA isolated from samples underwent reverse transcrip-
tion. Total RNA (1mg) was made up to a volume of 12.7ml
with diethylpyrocarbonate (DEPC) water. The samples
were then incubated at 65 C for 5min followed by incuba-
tion at 37 C for 2min. RT-PCR Mix (7.3ml) [4mlo f5  
MMLV RT buﬀer, 2ml dNTP’s (4mM), 1ml oligo dT15
(10mg/ml) and 0.3ml MMLV reverse transcriptase (5U/
ml)] was then added to the RNA solution and mixed by
pipetting. This was incubated at 37 C for 1h followed by
incubation at 95 C for 5min. cDNA was stored at  20 C.
cDNA from untransfected HeLa cells was used to make a
set of standards ranging from 0.2 to 0.000064. The sample
cDNA was diluted 1: 50 and 2ml of either sample cDNA or
the standards was added to each well of a 96-well plate
along with 8ml of master mix [1.8ml DEPC water
(Bioline, BIO-38031), 5ml Syber green (Invitrogen,
11733-038), 0.2ml ROX dye (Invitrogen, 11733-038) and
0.5ml of each the forward and reverse primer (stock
100mM) for each gene of interest]. The plate was sealed
with a clear plastic ﬁlm and centrifuged for 2min at
1200r.p.m. The plate was then placed in an Applied
biosystems 7900ht thermal cycler using the following
settings: 50 C for 2min, 95 C for 2min, then 40 cycles of
95 C for 3s and 60 C for 30s as well as a dissociation step.
Standard curves were created for all genes. Sample RNA
levels were normalized against results obtained for the
housekeeping genes. For this experiment glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and the 18S ribo-
somal subunit (18S) were used as housekeeping genes.
Larp1 primers: For (CAAGACACAGTTCAAACCCA),
Rev (GTTTCCGCTCATTAAGGCAG);
Larp2 primers: For (AGACAUUCCUCUACUUCUG),
Rev (GAACCAGAACAAGAAGAAC);
GAPDH primers: For (CATGGCCTCCAAAGGAGTA
AGAC), Rev (TCTCTTCCTCTTGTGCTCTTGCT);
18S primers: For (CACGCCAGTACAAGATCCCA),
Rev (CAGTCGCTCCAGGTCTTCAC).
Immunoprecipitation
HeLa cells were grown to 70–80% conﬂuency in 10-cm
dishes. The cells were then washed once with PBS
followed by the addition of 1ml of lysis buﬀer [1%
Triton X-100, 150mM NaCl, 50mM Tris–HCl (pH 7.2),
0.2mM Na3VO4, 50mM NaF, 2mM EDTA, 1mM
PMSF, 40ml/ml 25  protease inhibitor cocktail (Roche,
11697498001) and 10ml/ml 100  phosphatase inhibitor
cocktail (Calbiochem, 524625)]±RNAse A 2mg/ml
(Sigma, R6148) for 30min at 4 C. The lysates were then
centrifuged for 20min at 13–14000r.p.m. at 4 C. The
supernatant was removed and aliquoted as follows: 20ml
was used for direct loading control and 400ml each was
placed in a tube for IP sample and extract only. Lysis
buﬀer (400ml) was placed in a tube for antibody only
control. Larp1 antibody (3ml) was added to the IP
sample and antibody-only control tubes and incubated
rotated overnight at 4 C. Following this, 20–30mlo f
pre-washed protein G sepharose beads was added to the
IP sample, extract only and antibody only control tubes
and rotated for 1h at 4 C. The samples were then
centrifuged for 2min at 10000r.p.m. at 4 C and washed
twice with lysis buﬀer centrifuging as above, followed
twice with PBS. Sample buﬀer was added to direct
loading control, IP sample, extract only and antibody
only control and boiled for 5min at 95 C followed by
centrifugation at 10000r.p.m. for 2min. Samples were
resolved by SDS–PAGE and visualized by
immunoblotting.
7-methyl GTP sepharose beads pull-down
HeLa cells were grown to 70–80% conﬂuency in 10cm
dishes. The cells were then washed once with PBS
followed by the addition of 600ml lysis buﬀer [1%
Triton X-100, 150mM NaCl, 50mM Tris–HCl (pH 7.2),
0.2mM Na3VO4, 50mM NaF, 2mM EDTA, 1mM
PMSF, 40ml/ml 25  protease inhibitor cocktail (Roche,
11697498001) and 10ml/ml 100  phosphatase inhibitor
cocktail (Calbiochem, 524625)]±RNAse A 2mg/ml
(Sigma, R6148) for 30min at 4 C. The lysates were then
centrifuged for 20min at 13–14000r.p.m. at 4 C. The
supernatant was removed and aliquoted as follows: 20ml
was used for a direct loading control and 500ml was placed
in a clean labelled tube for the pull-down. Pre-washed
(30ml) 7-methyl GTP sepharose beads (GE Healthcare,
27-5025-01) was added to the 500ml of lysate and
rotated overnight at 4 C. The samples were then
centrifuged for 2min at 10000r.p.m. at 4 C and washed
twice with lysis buﬀer centrifuging as above, followed
twice with PBS. Sample buﬀer was then added to all the
tubes and boiled for 5min at 95 C followed by centrifu-
gation at 10000r.p.m. for 2min. Samples were then
resolved by SDS–PAGE and visualized by
immunoblotting.
RNAi
HeLa cells were seeded in either six-well plates (for protein
lysates) or 10cm dishes (for RNA lysates) and allowed to
reach 70–80% conﬂuency. A transfection mixture was
made as described: 100nM of a control scramble siRNA
(Euroﬁns: sense 50-GGUCCGGCUCCCCCAAAUG-30)
or 100nM of a mixture of two Larp1 siRNA sequences
(Euroﬁns: ﬁrst, sense 50-GAAUGGAGAUGAGGAUUG
5544 Nucleic Acids Research, 2010,Vol.38, No. 16CTT-30; second, sense 50-AGACUCAAGCCAGACAUC
ATT-30) was diluted 1: 10 with siRNA buﬀer (Euroﬁns)
and then diluted 1: 2 with optimem (Gibco, 51985-026).
This was left for 5min during which time transfection
reagent was diluted 1: 40 with optimem and also left for
5min. Equal volumes of siRNA mixture and transfection
reagent mixture were combined and left for 20 mins at
room temperature before being diluted 1: 12.5 with cell
media and added to each well. Cells were left for 24h
before a repeat transfection was performed as described
earlier. Cells were then left for a further 24h. To create cell
lysates the cells were washed with PBS before being
treated with 200ml lysis buﬀer [1% Triton X-100,
150mM NaCl, 50mM Tris–HCl (pH 7.2), 0.2mM
Na3VO4, 50mM NaF, 2mM EDTA and 1mM PMSF]
scraped and collected. RNA was extracted using the
Absolutely RNA Miniprep kit (Stratagene, 400800) as
per manufacturer’s instructions.
Antibodies and western blotting
Proteins were separated by SDS–PAGE using Amersham
MINIVE kit and then transferred onto a nitrocellulose
membrane followed by immunoblotting. Non-speciﬁc
binding sites on the nitrocellulose membranes were
blocked overnight with 5% milk in PBS-T (PBS:1%
Tween 20). Antibodies used were as follows: Larp 1
(SDI, 1:5000), PABP (Abcam, 1:2000), eIF4E, 4E-BP1,
p-eIF2a and eIF2a (cell signalling, 1:1000). Additional
antibodies to p-eIF4E, eIF4E, eIF4G and actin were
donated by Simon Morley (University of Sussex; used at
1:1000). Binding of the horseradish peroxidase
conjugated secondary antibodies was visualized by
enhanced chemiluminescence according to the manufac-
turer’s instructions and exposed to X-ray ﬁlm.
Mass spectrometry
Immunoprecipitates were generated as described earlier
and separated by SDS–PAGE gel electrophoresis.
Protein bands were excised from Coomassie-stained gels,
digested with trypsin and resulting peptides analysed by
LC-MS/MS using a nanoLC (Waters) coupled to a
Q-TOF2 mass spectrometer (Waters). Uninterpreted
fragmentation data was used to search the NCBI
database using the MASCOT search engine (Matrix
Science) allowing identiﬁcation of the protein(s) within a
gel band.
Methionine incorporation
The overall rate of protein synthesis in intact cells was
measured by the incorporation of [35S] methionine into
trichloroacetic acid-insoluble material. After
pulse-labelling for 1h with up to 15mCi/ml of the radio-
active amino acid (in the presence of the normal level of
methionine in the cell culture medium), cells were brieﬂy
centrifuged, washed once in cold phosphate-buﬀered
saline containing 100mM unlabelled methionine,
dissolved in 0.3M NaOH and precipitated with 10% tri-
chloroacetic acid in the presence of 0.5mg bovine serum
albumin carrier protein. Precipitates were washed with 5%
trichloroacetic acid and industrial methylated spirit and
the radioactivity determined by scintillation counting.
Flow cytometry
HeLa cells were incubated for 3 days at 37 C, the medium
was then removed from each well and placed in a 15ml
tube. Remaining cells were then trypsinized to detach
them from the well. This was achieved by washing the
cells ﬁrst with 0.5ml 1  trypsin and then adding 1ml of
1  trypsin to each well, and incubating for 5min at 37 C.
When the cells became detached they were removed
and added to the media in the 15ml tube. This was then
centrifuged at 1000r.p.m. for 5min. After centrifuga-
tion, the cell pellet was washed in 1  PBS solution
and ﬁxed by resuspending in 1ml 70% ice-cold ethanol,
added drop-wise, while vortexing. Samples were left on
ice for at least 30min, and then centrifuged at
1000r.p.m. for 5min. The ethanol solution was then
removed and the pellet resuspended in 500ml PBS with
200mg/ml RNase A (Qiagen), followed by 500ml PBS
with 200mg/ml of propidium iodide (Sigma). Samples
were then incubated in a 37 C waterbath for 30min and
resuspended using a syringe and 25G needle prior to
FACS analysis.
Cell staining
HeLa cells were grown to  50% conﬂuency on coverslips
in six-well plates. Cells were then transfected with Larp1
RNAi or control RNAi (as stated earlier) 48 and 24h
before staining. FLAG-Larp plasmid for Larp1
overexpression was introduced to the cells using Mega
Trans 1.0 transfection reagent (Origene) according to the
manufacturer’s protocol 24h before staining. On the day
of staining cells were rinsed with PBS and incubated with
PHEM ﬁxative (4% paraformaldehyde, 10mM EGTA pH
6.8, 4mM MgSO4, 60mM PIPES pH 6.8, 30mM HEPES
pH 7.0) for 10min. Cells were then washed in PBS twice
before being blocked and permeabilized in PBSTB (PBS,
0.1% Triton-X, 1% BSA) for 45min. Primary antibodies
were diluted as detailed below in PBSTB and applied to
cells and left overnight at 4 C. Following overnight incu-
bation, cells were washed several times in PBS before
being incubated with a secondary antibody diluted in
PBSTB. After 1h incubation, cells were washed three
times with PBS and mounted on slides with 25ml
Vectashield mounting medium containing
49,6-diamidino-2-phenylindole (Vector Laboratories).
Actin was visualized with the aid of Phalloidin-TRITC
(Fluka) diluted in PBSTB at 1: 500 and added at the
same time as the secondary antibodies.
For the mitotic staining the cell media was removed and
cells ﬁxed for 15min with 4% formalin in PBS. Cells were
washed three times for 5min with PBST (PBS + 0.1%
Triton X-100) followed by 1h of blocking with PBNT
(PBST + 4% normal goat serum). Primary antibody
against Cyclin B was applied over night at 4 C followed
by three washes of 5min. Anti-rabbit Alexa594 secondary
antibody was applied for 2h at room temperature
followed by incubation with Hoechst 33258 (1:1000
Nucleic Acids Research, 2010,Vol.38, No. 16 5545dilution) for 10min. Cells were washed three times for
5min with PBST before being analysed.
Migration assay
HeLa cells were seeded in six-well plates and allowed to
reach  70% conﬂuency. The cells were then treated with
RNAi against Larp1 or control RNAi as mentioned
above. After two transfections of 24h each, plate was
washed once in PBS which was removed and replaced
with low serum media DMEM without phenol red
(Gibco) supplemented with 1% FCS and 25mM sodium
pyruvate for 6h. Wounds were made by scratching cells
using a sterile pipette tip and evaluated under phase
contrast microscopy at 0, 12, 15 and 18h. To generate
confocal images, cells were seeded and treated with
control and Larp1 RNAi as above. At 12h following
scratch, cells were ﬁxed, permeabilized and
immunostained as described earlier.
Statistics
Statistical analysis was used to compare cell characteristics
between treatment pairs, i.e. FLAG Larp1 versus trans-
fection control and Larp1 RNAi versus control RNAi.
The median (inter-quartile range) score was calculated
for each variable. The P-value, a measure of diﬀerence
between the variables was obtained using the
non-parametric Mann–Whitney U test.
RESULTS
Human Larp1 interacts with PABP and eIF4E
The relative mRNA levels of Larp1 and Larp1b were
assayed by Qualitative real time PCR (qPCR)
(Figure 1B). We demonstrated that Larp1 was 40  more
abundant than Larp1b and that siRNA to Larp1b did not
cause a quantiﬁable phenotypic change in HeLa cells (data
not shown). Thus the work described in this article is
focused on Larp1. As Drosophila Larp1 has already
been demonstrated to interact with Drosophila PABP,
we investigated whether this interaction was also
conserved in human cells. Larp1 interacting proteins
were assessed in HeLa cells lysates by immunopre-
cipitation using protein-G sepharose beads coated with
anti-Larp1 or anti-PABP antibodies (Figure 1C).
Immunoprecipitated proteins were separated by SDS–
PAGE and immunoblotted. This showed that PABP and
Larp1 co-immunoprecipitated in an interaction that was
not perturbed following RNAse treatment. This excludes
an indirect interaction between the proteins via mRNA.
To determine whether cap-binding proteins were present
in complex with Larp1 and PABP, 7-methyl GTP
sepharose beads were used. HeLa cell lysates were
incubated with the 7-methyl GTP sepharose beads and
proteins pulled down in this interaction were separated
by SDS–PAGE and immunoblotted. As expected, eIF4E
was bound to the 7-methyl GTP beads, but PABP, eIF4G
and Larp1 were also present (Figure 1D). Neither the
interactions between eIF4E and PABP or eIF4E and
eIF4G were abolished after Larp1 RNAi (data not
shown), suggesting these associations are non-Larp1
dependent.
Larp1 may have a role in translation initiation
PABP is known to stimulate translation initiation by in-
directly interacting with eIF4E (via an interaction with the
cap-complex scaﬀold protein, eIF4G) and circularising the
mRNA (28) and, in addition, PABP has been found to
interact with polysomally-associated mRNAs (29) and it
has a direct role in 60S subunit joining (30). To determine
whether depletion of Larp1 might have an eﬀect upon
polysomal association of mRNAs, HeLa cells were trans-
fected with Larp1 siRNA and the subsequent ribosome
sedimentation proﬁles were examined two days following
transfection (Figure 2A). Compared to controls (cells
untransfected or transfected with ‘control’ siRNA) the
proﬁles demonstrated an increase in the amount of
subpolysome components (40S, 60S and 80S) and a
relative decrease in polysomes after Larp1 RNAi (using
20 and 40nM siRNA) treatment, suggesting that Larp1
may be involved either directly or indirectly in an early
stage of translation initiation. To assess the extent of in-
hibition, global protein synthesis rates in cells treated with
Larp1 siRNA and non-sense siRNA were compared using
35S methionine incorporation (Figure 2B). This showed a
15% reduction in total protein synthesis in cells which
lacked Larp1. To determine whether levels of Larp1 had
an eﬀect on the expression or phosphorylation status of
canonical initiation factors, western blotting analysis was
performed on protein lysate samples obtained from HeLa
cells treated with either Larp1 siRNA or non-sense
siRNA. The only signiﬁcant changes observed after loss
of Larp1 was an increase in the hypophosphorylated form
of 4E-BP1 (Figure 2C) and an increase in the binding of
Target Primary antibody Secondary Antibody
Larp1 Larp1 (Strategic Diagnostic) 1: 100 Anti-Rabbit Cy5, (Invitrogen) 1: 500
Microtubules YL1/2 aTubulin antibody (Oxford Biotechnologies) 1: 50 Anti-rat Alexa 488, (Molecular Probes) 1: 400
Centrosomes GTU88 g-Tubulin (Sigma) 1: 200 Anti-mouse Rhodamine, (JIR) 1: 100
Cyclin B Cyclin B (Sc-752 Santa Cruz) 1: 100 Anti-rabbit Alexa 594, (Molecular Probes) 1: 500
Total actin Alexa Fluor Phalloidin (A22283-Invitrogen) 1: 500 –
b-actin b-actin (Ab8227-AbCam) 1: 100 Anti-rabbit Alexa 594, (Molecular Probes) 1: 500
g-actin g-actin (A8481- Sigma) 1: 100 Anti-mouse Alexa 488 (Molecular Probes) 1: 500
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eﬀect of reducing the amount of eIF4E available for eIF4F
complex formation, in agreement with the observed reduc-
tion in total protein synthesis. To determine whether Larp1
may be directly involved in binding to the translational
machinery sucrose density gradients were fractionated
and western blotting was performed to determine the
location of Larp 1 protein (Figure 2E). Larp 1 was found
to be associated primarily with pre-polysomal subunits.
Loss of Larp1 results in a cell cycle arrest and
apoptotic phenotype
FACS proﬁling in HeLa cells treated with Larp1 or
control siRNA demonstrated that Larp1 knockdown
caused an accumulation of 4C cells (relative to 2C cells)
consistent with G2/M arrest along with a sub G1 peak
signifying cell death (Figure 3A). Immunostaining (here
in U2OS cells) following Larp1 RNAi demonstrated (as
previously observed in Drosophila Larp mutants)
abnormal chromatin condensation, failure of bipolar
mitotic spindle formation, abnormal centrosome migra-
tion, irregular nuclear morphology and defective cytokin-
esis (Figure 3B). This was quantiﬁed (Table 1) showing
increased apoptosis, a greater number of chromosome
defects and a mitotic arrest in cells treated with Larp1
siRNA when compared to controls. In addition, in
control cells, chromosomes were aligned in a tight meta-
phase conﬁguration [Figure 3C (i)] at which point Cyclin
B levels were high. As they progressed into anaphase,
Cyclin B was abruptly degraded [Figure 3C (ii)]. In
contrast, the majority of Larp1 depleted mitotic cells
showed chromosomes scattered on the mitotic spindle in
the presence of elevated levels of Cyclin B [Figure 3C (iii)],
suggesting defective chromosome congression or
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Figure 2. (A) Ribosome sedimentation proﬁles using HeLa cells treated with either Larp1 siRNA (20 and 40nM), control siRNA (20nM) or
untreated. Compared to controls, the proﬁles demonstrated a considerable increase in the ratio of the subpolysome components (40S, 60S and
80S) compared to polysomes after Larp1 siRNA (20 and 40nM) treatment, indicating that loss of Larp1 results in defective translation initiation. (B)
Global protein synthesis rates in cells treated with Larp1 siRNA and non-sense siRNA were compared using 35S methionine incorporation and show
that there is a 15% reduction in total protein synthesis in cells which lack Larp 1. (C) Western blotting of HeLa cell lysates pre and post Larp1
RNAi probed with antibodies for translation initiation components. Loss of Larp1 did not alter levels of eIF4G, eIF4E or eIF2a, but was associated
with increase in levels of hypophosphorylated 4E-BP1. (D) Western blotting following cap pull-down of HeLa lysates pre- and post-Larp1 RNAi
showed increased association between eIF4E and 4E-BP1. (E) Western blotting of proteins precipitated from elute fractions obtained during
ribosome sedimentation proﬁling showed a predominant association between Larp1 and the pre-polysome components, the 40S, 60S and 80S
ribosome fractions.
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spindle assembly checkpoint.
Larp1 is localized to cell protrusions in HeLa cells and
Larp1 over-expression causes multiple lamellopodia while
loss of Larp1 results in an inhibition of cell migration
By immunostaining HeLa cells using anti-Larp1 antibody,
we demonstrated the presence of Larp1 within the cyto-
plasm and at the leading edge of cells (Figure 4A). The
presence of Larp1 at the leading edge was most
pronounced in cells over-expressing Larp1 (FLAG-
Larp1) and, when compared to controls, these cells
demonstrated a greater number of lamellopodia
containing co-localized actin and Larp1. To quantify,
cells were measured in two dimensions (area) and the
number of ﬁlopodia and lamellipodia were counted and
data was analysed statistically (Table 2). Cells
over-expressing Larp1 (FLAG-Larp1) were signiﬁcantly
smaller by area, had fewer ﬁlopodia (even when number
was controlled for cell size) but a greater number of
lamellipodia compared to transfection reagent-alone
controls. In contrast, cells treated with Larp1 RNAi
were larger by area, had a greater number of ﬁlopodia
and fewer lamellipodia compared to cells treated with
control RNAi. As lamellipodia are a feature of actively
migrating cells, we explored the eﬀect of Larp1 on cell
γ-tubulin α-tubulin DNA
G1
G2/M
Larp1 RNAi
Apoptosis
Control RNAi
i ii iv iii
Control RNAi Larp1 RNAi
B A
C
Figure 3. (A) Flow cytometry proﬁle of HeLa cells following Larp1 RNAi treatment (red hatched) compared to control RNAi (black line). In cells
treated with Larp1 siRNA, an increase in 4C relative to 2C cells is observed along with an increase in cell death (arrow). RNAi was performed using
20nM Larp1 siRNA and 20nM control siRNA. (B) Immunoﬂuorescence showing U2OS cells during mitosis compared to controls (inset). Following
knockdown of Larp1 after siRNA treatment, cells have a distinct ‘scattered chromosome’ appearance. Alpha-tubulin (green), g-tubulin (red) and
DNA (blue) (scale bar=10mm) compared to controls. (C) In control treated HeLa cells Cyclin B levels are elevated in metaphase (i) but are
decreased following anaphase (ii). Following Larp1 RNAi, levels of Cyclin B remain high, showing the characteristic ‘scattered chromosome’
phenotype and without transition to anaphase (iii and iv) (scale bar=10mm).
Table 1. Quantiﬁcation of defects in HeLa cells following RNAi to Larp1, control dsRNA and transfection reagent alone
Transfection reagent only control Control (non-sense RNAi) Larp1 RNAi
Apoptosis (preG1) 7.02%±0.84 7.8%±1.04 14.38%±1.93
Mitotic index 100%±0 100.8%±4.7 174.92%±20.18
Cell density 100%±0 75.8%±9.04 41.99%±4.35
Chromosome defects 2.14%±1.08 1.83%±0.67 6.33%±1.44
Following Larp1 RNAi, there is a greater percentage of sub G1 cells (indicative of apoptosis) and a higher number of cells with chromosome defects
compared to controls. The mitotic index was also elevated following Larp1 RNAi.
5548 Nucleic Acids Research, 2010,Vol.38, No. 16motility using a scratch assay. A monolayer of HeLa cells
was grown to conﬂuence on a glass coverslip, scored to
produce an open furrow using a pipette tip and then
examined at a series of time points. In controls the
wound gap was reﬁlled by 18h, but in cells treated with
Larp1 RNAi there was little or no ﬁlling of the gap after
18h (Figure 4B). This is demonstrated graphically (Figure
4C).This assay was repeated but cells at the scratch margin
were ﬁxed after 12h and stained with antibodies to Larp1
and actin (total). Cells at the scratch furrow edge were
then examined using confocal microscopy. This
demonstrated a concentration of Larp1 at the cellular
leading edge and within protrusions in the direction of
cell travel i.e. towards the furrow (arrowheads,
Figure 4D).
Larp1 interacts with cytoskeletal proteins
To determine with which other proteins Larp1 interacted,
immunoprecipitation experiments were performed using
cell lysates incubated with protein-G sepharose beads
coated with anti-Larp1 antibody. The subsequent
immunoprecipitates were analysed by mass spectrometry
(Table 3). To control for PABP-interacting proteins, a
second set of immunoprecipitates were analysed using
Control RNAi
FLAG -Larp1
DNA Larp1 actin
Scale bar = 10μM HeLa cells 
Red – anti-actin
Blue – DNA
Green – Larp1
Larp1 RNAi
Transfection
reagent control
untransfected
control
i) ii) iii) iv)
A
Figure 4. (A) Immunoﬂuorescence of HeLa cells following treatment with control RNAi, Larp1 RNAi and in cells transfected with Larp1
over-expressing construct (FLAG-Larp1) examined using confocal microscopy. Panels show images in combined colour channel (i), blue channel
(DNA) (ii), red channel (actin) (iii) and green channel (Larp1) (iv). Larp1 over-expression (FLAG-Larp1) causes a mesenchymal-like phenotype, with
cells displaying multiple lamellipodia (white arrow). Cells treated with Larp1 RNAi were larger and had more ﬁlopodia when compared to controls.
(B) Scratch migration assay in HeLa cells treated with Larp1 siRNA or control siRNA control. An open furrow was generated by scratching
conﬂuent cells using a pipette tip. Conﬂuency was restored in controls between 15 and 18h. However, in cells treated with Larp1 siRNA, conﬂuency
was not restored after 18h. The distance between furrow edges in the control and Larp1 siRNA treated cells was measured and is presented
graphically in (C). In (D), cells were ﬁxed and immunostained 12h after scratch. Cells at the furrow edge were examined using confocal microscopy.
This showed, in cells treated with control RNAi (top panel), a concentration of Larp1 within their leading edge (small arrows in magniﬁed ﬁgures) in
the direction of cell travel. This was not observed after Larp1 RNAi (bottom panel), where cells were closely adherent to each other without a clear
direction of travel.
Nucleic Acids Research, 2010,Vol.38, No. 16 5549beads coated with anti-PABP antibody, and overlapping
candidates identiﬁed by mass spectrometry were excluded.
This showed that Larp1 was in a complex with cytoskel-
etal proteins, as well as proteins required for transcription,
protein synthesis, cell signalling and metabolism.
Cytoskeletal proteins identiﬁed as being in complex with
Larp1 included tubulin, keratins, actin and myosin as well
as actin-binding proteins: plectin, spectrin,
actinin and tropomyosin and actin-capping proteins
CapZA and CapZB. The tight junction protein, zona
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Figure 4. Continued.
Table 2. Phenotype quantiﬁcation of cell size, ﬁlopodia number and number of projections in HeLa cells either over-expressing Larp1
(FLAG-Larp1), after treatment using transfection reagent alone, cells treated with Larp1 RNAi or control RNAi
Control RNAi
median (IQR)
n=192
Larp1 RNAi
median (IQR)
n=178
P-value FLAG Control
median (IQR)
n=202
FLAG Larp1
median (IQR)
n=234
P-value
Filopodia 35 (23–53) 61 (43–75) <0.001 40 (25–55) 35 (22–47) 0.04
Area 2000 (1440–2800) 2320 (1750–3444) 0.006 2400 (1600–3400) 1500 (1000–2275) <0.001
Protrusions 0 (0–1) 0 (0–0) 0.005 0 (0–2) 2 (0–3) <0.001
Filopodia / area 0.016 (0.011–0.029) 0.026 (0.015–0.038) <0.001 0.018 (0.009–0.026) 0.023 (0.013–0.036) 0.001
Protrusions / area 0.000 (0.000–0.001) 0.000 (0.000–0.000) 0.004 0.001 (0.000–0.002) 0 (0–6) <0.001
Data analysed using Mann–Whitney U test.
5550 Nucleic Acids Research, 2010,Vol.38, No. 16occludens 1 (ZO-1) was also identiﬁed along with other
cell–cell junction proteins such as tropomyosin and
spectrin.
Larp1 aﬀects the distribution of b- and c-actin
To address the eﬀect of Larp1 on cytoskeletal organiza-
tion, we observed the distribution of two isoforms of actin
(b and g) in HeLa cells following Larp1 RNAi and
over-expression, compared to controls (Figure 5). In
untreated cells or cells transfected with non-sense RNAi,
b-actin was observed within stress ﬁbres and co-localized
with g-actin in cortical ﬁbres. After Larp1 RNAi,
stress ﬁbres were reduced and both b and g actin were
diﬀusely distributed throughout the cytoplasm. In cells
in which Larp was over-expressed (FLAG-Larp1),
g-actin was concentrated at the leading edge and within
lamellipodia. Stress ﬁbres were absent in these cells and
b-actin was diﬀusely distributed throughout the
cytoplasm.
DISCUSSION
To summarize our ﬁndings, we have showed that, like its
Drosophila counterpart, Larp1 interacts with PABP but
also that Larp1 is in complex with the mRNA cap-binding
protein eIF4E. Phenotypically, loss of Larp1 causes a
mitotic arrest, apoptosis and changes in cell morphology
such as a reduction in formation of migratory
lamellipodia. The mitotic phenotype observed in HeLa
cells following a reduction of Larp1 expression by
siRNA is consistent with that observed in Drosophila
Larp mutants, namely failure of centrosome separation
and abnormal migration around the nuclear periphery,
as well as defective chromosome condensation, nuclear
morphology and cytokinesis. The mitotic arrest phenotype
observed after Larp1 RNAi (and in Drosophila Larp
mutants) could be as a result of reduced synthesis of
cytoskeletal proteins, such as tubulin and keratins,
which are required for ordered cell-cycle progression as
well as for migration, although whether Larp1 has a
direct or indirect eﬀect in this process and the exact can-
didates responsible for each characteristic have yet to be
resolved.
When over-expressed, Larp1 causes an increase in
number of lamellipodia and a switch to a mesenchymal-
like or migratory phenotype while loss of Larp1 in HeLa
cells caused defective ‘wound healing’ as evidenced in our
scratch assay. In addition, Larp1 appears to alter the
balance between b and g-actin expression and stress ﬁbre
formation. Although these two isoforms of cytoplasmic
actin diﬀer by only four amino acids, they are known to
have functional diversity in the migrating cell, and it is
possible that their expression is post-transcriptionally
regulated by Larp1 (31). After immunostaining, we
demonstrated dense Larp1 staining within lamellipodia
and at the leading edge of HeLa cells, which was more
pronounced in cells over-expressing Larp1. Loss of Larp1
by RNAi caused an increase in number of ﬁlopodia per
cell, while ﬁlopodia numbers were decreased in cells
over-expressing Larp1. We showed by immunoﬂuores-
cence that, although Larp1 was present in lamellipodia,
it did not localize to ﬁlopodia.
Although the data suggest that Larp1 has a role in the
regulation of protein synthesis, it is unclear as to whether
the eﬀect of Larp1 is direct or indirect. In C. elegans,
LARP-1 was observed in P-bodies and it is possible that
Larp1 may have a role in traﬃcking a selection of
mRNA transcripts to or from stress granules within the
cytoplasm. Both eIF4E and PABP have been identiﬁed
within cytoplasmic granules (32) and this mechanism
may provide a means to protect mRNA transcripts
until their protein products are required within the
cell. We show here that Larp1 interacts with cytoskeletal
components which could alternatively suggest a model
whereby Larp1, perhaps in complex with eIF4E,
journeys around the cytoskeleton to activate translation
at speciﬁc sites, such as at the leading edge. Our ﬁnding
of Larp1 at the leading edge in HeLa cells provides,
albeit circumstantial, evidence to support this. These
data raise exciting questions about the role of Larp1 in
mRNA translation and cell migration, and suggest Larp1
may have relevance in a number of conditions in which
these processes are disrupted, such as in tissue regener-
ation and cancer.
Table 3. Proteins identiﬁed by mass spectrometry as interacting with
Larp1 using lysates of two isogenic epithelial ovarian cancer cell
lines, PE01 and PE04
Cytoskeleton Protein synthesis
(b actin hnRNPE, G, Q2
a2 (smooth muscle) actin 40S ribosome proteins S14, S25
actin prepeptide 60S ribosome proteins L22, L23A
a-1, a-4 actinin nucleolin
CAPZA and CAPZB PABP
a-tubulin RNA (DEAD box) helicase
keratins 1, 2e, 4, 5, 6B, 7,
8, 9, 10, 18, 19
LIM-domain containing protein Transcription / chromatin
myosins 1, 2, 6, 9 histones 1B, 2A, 4, testicular H1
plectin 1 Thymopoietin a (LAP2 alpha)
a-2 and b-spectrin YB1
Tropomysin
zona occludens 1
Chaperone / cell cycle /
cell signalling
Metabolism Hsp70 and 90
Lactate dehydrogenase A Protein phosphatase 1
Phenylalanine hydroxylase Ig k light chain
mitotic spindle associated protein
annexin A2
EF hand domain family D2
14-3-3 s and y
ubiquitin
SUMO
Clathrin
SLC25A4
Candidate proteins identiﬁed using PABP controls were excluded.
Proteins were grouped by function. This showed that Larp1 predom-
inantly interacts with cytoskeletal proteins, but also proteins required
for protein synthesis, chaperones, cell signalling, transcription and
metabolism.
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